A phase I/II study of altered fractionated IMRT alone for intermediate T-stage oropharyngeal carcinoma.
about
Risk model and nomogram for dysphagia and xerostomia prediction in head and neck cancer patients treated by radiotherapy and/or chemotherapy.The treatment of oral cancer: an overview for dental professionals.New radiotherapy techniques do not reduce the need for nutrition intervention in patients with head and neck cancer.Prospective study on the dose distribution to the acoustic structures during postoperative 3D conformal radiotherapy for parotid tumors: dosimetric and audiometric aspects.Lhermitte sign and myelopathy after irradiation of the cervical spinal cord in radiotherapy treatment of head and neck cancer.
P2860
A phase I/II study of altered fractionated IMRT alone for intermediate T-stage oropharyngeal carcinoma.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
A phase I/II study of altered ...... stage oropharyngeal carcinoma.
@en
A phase I/II study of altered ...... stage oropharyngeal carcinoma.
@nl
type
label
A phase I/II study of altered ...... stage oropharyngeal carcinoma.
@en
A phase I/II study of altered ...... stage oropharyngeal carcinoma.
@nl
prefLabel
A phase I/II study of altered ...... stage oropharyngeal carcinoma.
@en
A phase I/II study of altered ...... stage oropharyngeal carcinoma.
@nl
P2093
P2860
P1476
A phase I/II study of altered ...... stage oropharyngeal carcinoma.
@en
P2093
Brent Parker
Eugene J Endres
G Brandon Gunn
Giuseppe Sanguineti
Maria Pia Sormani
P2860
P2888
P304
P356
10.1007/S00066-010-2093-6
P577
2010-08-30T00:00:00Z